1655 Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Kim Linton

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

1 results
- Title(descending)

EU approval of epcoritamab for treatment of relapsed/refractory lymphoma
Linton, K. (Participant)
Impact: Policy